Signal active
Investment Firm
Investment portfolio
investments
14
Diversity investments
1
Lead investments
2
Number of exits
undefined
Investments
14
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 09, 2021 | Eirion Therapeutics | Biotechnology | 40.0M |
| Nov 14, 2022 | Validic | Apps | 12.0M |
| Jan 05, 2023 | - | - | 37.7M |
| Oct 11, 2023 | AOA | Biotechnology | 17.0M |
Exits
0
Funding Timeline
Funding rounds
14
Investors
0
Funds
0
Funding Rounds
14
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 09, 2021 | Series A - Eirion Therapeutics | - | 40.0M | - |
| Nov 14, 2022 | Venture Round - Validic | - | 12.0M | - |
| Jan 05, 2023 | Series D - Palvella Therapeutics | - | 37.7M | - |
| Oct 11, 2023 | Series A - AOA | - | 17.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
Funding Round
Oct 11, 2023
AOA raised $17000000 on 2023-10-11 in Series A
Funding Round
Jan 05, 2023
Palvella Therapeutics raised $37700000 on 2023-01-05 in Series D
Funding Round
Nov 14, 2022
Validic raised $12000000 on 2022-11-14 in Venture Round
Funding Round
Mar 09, 2021
Eirion Therapeutics raised $40000000 on 2021-03-09 in Series A
Funding Round
Apr 09, 2020
Dorsata raised $5200000 on 2020-04-09 in Series A